Global Leukapheresis Market 2019 - Key Players, Industry Growth, Segmentation


Posted November 19, 2019 by roberthenric

The Leukapheresis Market is expected to reach USD 27.7 million by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%.
 
November 19, 2019 — The major factors driving the growth of the market include the rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations.

According to a new market research report "Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Leukopak (Mobilized, Non-Mobilized, Human Primary Cells), Application (Research, Therapeutic), End User (Hospitals, Research Institute) - Global Forecast to 2023", published by MarketsandMarkets™

Major Market Drivers

Increasing incidence and prevalence of leukemia;

Globally, the incidence of leukemia has risen significantly. According to the NIH National Cancer Institute in 2015, 405,815 people were suffering from leukemia in the US. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015). The NIH also estimates that the number of new cases may reach 60,300 in 2018. According to the Leukemia & Lymphoma Society, from 2010 to 2014, leukemia was the sixth-most-common cause of cancer deaths globally.

Increasing number of blood donations;

The global demand for blood and blood components is on the rise. In the US alone, ~44,000 units of blood are required every day in hospitals and emergency treatment facilities. Approximately 21 million units of blood components are transfused every year in the US. The requirement of leukocytes/WBCs is increasing with the increase in demand for leukopaks in clinical research and the rising number of clinical trials for the development of CAR-T therapy for leukemia.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148

Market Segmentation:

On the basis of type of leukapheresis products, the leukapheresis disposables segment is estimated to account for the largest share of the leukapheresis products market in 2018. The large share of this segment can be attributed to the repeated consumption of disposables in leukapheresis procedures. The increasing applications of leukapheresis procedures for the isolation of primary cells from blood for cell therapy research applications is primarily driving the growth of this market segment during the forecast period.

Based on applications, the research applications segment is expected to account for the largest share of the global leukapheresis products market in 2018. The large share of this segment can be attributed to the growing adoption of leukapheresis products in research activities propelled by increasing research activities being undertaken for cancer, immunology, infectious diseases, drug discovery, regenerative medicine, and cell-based therapies.

By end user, the blood component providers & blood centers segment is expected to account for the largest share of the global leukapheresis products market in 2018. Growth in this market is primarily driven by the increasing number of blood donations, growing demand for leukopaks for the development of CAR-T therapy, and rising demand for leukopaks in clinical conditions like cancer.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148
Asia Pacific to dominate the market in 2018

Asia Pacific is expected to account for the largest share of the Leukapheresis Market in 2018, followed by North America. The increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies focusing on cell therapy research are factors are driving the growth of this regional segment.

The prominent players in the global Leukapheresis Products Market are Asahi Kasei Medical (Japan), Fresenius (Germany), Haemonetics Corporation (US), Terumo BCT (US), STEMCELL Technologies (Canada), and Macopharma (France). Some prominent players in the Leukopaks Market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US).
-- end ---
Contact Email [email protected]
Issued By marketsandmarkets
Phone 18886006441
Business Address marketsandmarkets
630 Dundee Road Suite 430 Northbrook
Country United States
Categories Health , Marketing , News
Tags Leukapheresis Market , Leukapheresis Products Market , Leukopaks Market
Last Updated November 19, 2019
Loading...